Stakes

Sanofi to sell stake in Regeneron

Sanofi SA said the company would sell its stake in Regeneron Pharmaceuticals Inc., but would not change their ongoing collaboration.

May 25, 2020/by Reuters Health

Bristol-Myers to invest in Compugen, collaborate in clinical trials

Antibodies, Blockbusters, Business, Checkpoint Inhibitors, Clinical Trials, Immune System, R&D, Shares, Solid Tumors, Stakes

Bristol-Myers Squibb and Israel’s Compugen will collaborate in clinical trials for patients with advanced solid tumors.

October 11, 2018/by Reuters Health

Ackman, Valeant Pay $290M to End Allergan Insider Trading Lawsuit

Business, Deals, Insider Trading, Investments, Stakes

Pershing Square, a hedge fund run by activist investor William Ackman, and Valeant decided to settle an insider trading lawsuit with Allergan and pay $290 million.

January 2, 2018/by BioSpace

SEC Filing Reveals GlaxoSmithKline’s 13 Percent Stake in Spero Therapeutics

Antibiotics, Antimicrobials, Bacterial Infections, Biomedical Advanced Research and Development Authority (BARDA), Biotech, Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator (CARB-X), Department of Defense, Department of Health and Human Services (HHS), Filings, National Institute of Allergy and Infectious Diseases (NIAID), SEC, Shares, Stakes

A filing with the U.S. Securities and Exchange Commission (SEC) indicates that the UK’s GlaxoSmithKline has a 13 percent stake in Spero Therapeutics, with 1,854,006 shares in the Massachusetts biotech company.

November 17, 2017/by BioSpace

Novartis to Hold On to Its 33 Percent Stake in Roche – For Now

Analysts, Big Pharma, Generics, Ophthalmics, Pricing, Shares, Stakes

Basel, Switzerland-based Novartis has decided not to sell its $14 billion stake in Swiss rival Roche.

October 12, 2017/by BioSpace